News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
Presentation TVT 2017 A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations Presenter: Mark Reisman, Gregg W. Stone, Francesco Maisano June 15, 2017
Presentation TVT 2017 Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference? Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy June 15, 2017
Presentation TVT 2017 TAVR in Perspective Evolution, Impact, and Future Expectations Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon June 15, 2017
Presentation TVT 2017 Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow June 15, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017